WASHINGTON, DC – Dr. Vinay Prasad, the polarizing official who led U.S. vaccine oversight under the Trump administration, has stepped down from his position at the Food and Drug Administration (FDA) ...
On the Friday after Thanksgiving, Vinay Prasad, the FDA’s top vaccine regulator, made a claim that shocked the public-health establishment. “For the first time,” he wrote in a leaked email to his ...
The head of the Food and Drug Administration’s vaccine division claimed in a leaked email that “at least 10 children” died from COVID-19 vaccination, using that to justify major vaccine regulatory ...
Kim Strassel speaks with healthcare policy expert Avik Roy about the "original sin" of American healthcare policy, the added mess that is the Affordable Care Act, and what Republicans can do to lower ...
Prasad’s memo, meanwhile, also suggests changes are afoot for routine shots, including the seasonal flu vaccine. “We will revise the annual flu vaccine framework, which is an evidence-based ...
The FDA is planning to tighten its regulations for vaccines, according to an internal email sent by Vinay Prasad, M.D., who heads up the agency’s Center for Biologics Evaluation and Research (CBER).
Sacramento city leaders and community members gathered to support Alvin Prasad, who remains in a coma after an attack in the Lavender Heights district that police are investigating as a hate crime. 11 ...
Through his leadership at the FDA's Center for Biologics Evaluation and Research (CBER), Vinay Prasad, MD, MPH has pushed out at least 7 senior leaders and created an environment that employees worry ...
Get started with Java streams, including how to create streams from Java collections, the mechanics of a stream pipeline, examples of functional programming with Java streams, and more. You can think ...
Because he can masterfully feign concern over evidence and data, Dr. Prasad is the Shohei Ohtani of spreading doubt and mistrust about vaccines. It’s no surprise that under his “leadership”, diseases ...
On July 29, Dr. Vinay Prasad abruptly left his job at the U.S. Food and Drug Administration (FDA); less than two weeks later, on August 9th, he returned. It’s been a long, strange season for the ...
A top official at the Food and Drug Administration steps down after the agency changes course on a treatment for Duchenne muscular dystrophy. What does this say about the Trump Administration's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback